Webinar originally hosted November 18, 2021.
Magali Haas, MD, PhD
CEO & President, Cohen Veterans Bioscience
Dr. Haas is founder of Cohen Veterans Bioscience (CVB), a global organization that leads pioneering efforts in PTSD and TBI research, including clinical trials, biotechnology, genetics, and biomarker discovery. She has more than 15 years of pharmaceutical leadership experience in neuroscience clinical development, translational medicine, and diagnostics, primarily at J&J. Dr. Haas has spearheaded the Brain Trauma Blueprint initiative to establish a national roadmap for PTSD & TBI precision therapeutics research.
Jamshid Ghajar, MD, PhD, FACS
President Emeritus, Brain Trauma Foundation
Dr. Ghajar is a board-certified neurosurgeon. In 2014, he joined the neurosurgery faculty at Stanford, where he is a clinical professor of neurosurgery and the Moghadam Family Director of the Stanford Brain Performance Center, Stanford University School of Medicine. He founded the Brain Trauma Foundation to develop and implement best practice guidelines for TBI, with the goal of improving patients’ lives.
